A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

By Kalviainen R.   Brodie M.J.   Duncan J.   Chadwick D.   Edwards D.   Lyby K.   for the Northern European Tiagabine Study Group  

Epilepsy Research, Vol. 30, Iss. 1, 1998-03 ,pp. : 31-40

Elsevier

Access to resources Recommend Favorite

Acetyl-L-Carnitine as an Adjunctive Therapy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Placebo-Controlled Trial

By Abbasi Seyed-Hesameddin  

Child Psychiatry and Human Development, Vol. 42, Iss. 3, 2011-06 ,pp. : 367-375

Springer Publishing Company

Access to resources Recommend Favorite

The KEEPER&unknown; trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study

By Morrell M.J.   Leppik I.   French J.   Ferrendelli J.   Han J.   Magnus L.  

Epilepsy Research, Vol. 54, Iss. 2, 2003-05 ,pp. : 153-161

Elsevier

Access to resources Recommend Favorite

Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures

By Pietka E.   H. K.H.   Ben-Menachem E.   Soderfelt B.   Hamberger A.   Hedner T.   Persson L.I.  

Epilepsy Research, Vol. 21, Iss. 3, 1995-07 ,pp. : 231-236

Elsevier

Access to resources Recommend Favorite

Corrigendum to ''The KEEPER(TM) trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study'' [Epilepsy Res. 54 (2003) 153-162]

By Morrell M.J.   Leppik I.   French J.   Ferrendelli J.   Han J.   Magnus L.  

Epilepsy Research, Vol. 56, Iss. 2, 2003-10 ,pp. : 209-210

Elsevier

Access to resources Recommend Favorite